Smartwatch ECG & AFib Alerts

Press two fingers to a watch crown and 30 seconds later you have a medical-grade heart trace — a capability that would have seemed like science fiction a decade ago. Devices from Apple, Samsung, and Google, plus dedicated monitors like KardiaMobile, now pair on-demand ECG recordings with automatic AFib alerts. The question isn't whether the sensors are real. It's what they're actually good at.

What the Sensor Actually Measures

The classic ECG uses 12 leads placed across the chest and limbs to capture the heart's electrical activity from many angles. A smartwatch captures a single lead (roughly Lead I) by closing a circuit between the wrist sensor and your opposite fingertip. That single view is excellent for detecting the most important rhythm problem — atrial fibrillation (AFib), an irregular, often rapid rhythm that raises stroke risk — but it is a narrow window, not a full cardiac workup.

What the Alerts Are Cleared to Detect

These features are genuinely FDA-cleared, and the evidence is real:

On-demand ECG recordings (Apple Watch, KardiaMobile, Samsung Galaxy Watch) classify the 30-second trace as AFib, sinus rhythm, or "inconclusive," and let you export a PDF for a clinician. Validation studies report sensitivity and specificity in the high 90s for AFib detection on these clean, on-demand traces.
Irregular rhythm notifications (Apple Watch, Fitbit, Google Pixel Watch) use photoplethysmography (PPG) to sample your pulse periodically through the day and notify you when an irregular pattern is detected. The landmark Apple Heart Study (2019) validated this approach: about 0.5% of participants received an alert, and 84% of those who subsequently wore a confirmatory patch had AFib episodes.
High/low heart rate alerts flag sustained rates outside a set range — useful, but a screening aid, not a diagnosis.

What It Can't Catch

Heart attacks (ischemia). Single-lead consumer ECGs are not validated for detecting acute coronary occlusion. If you have crushing chest pain or shortness of breath, do not record a trace and wait for the result — seek emergency care.
Many other arrhythmias. Paroxysmal SVT, ventricular arrhythmias, and heart block may be missed or misclassified by single-lead devices.
Structural heart disease. Hypertrophic cardiomyopathy, valve disease, and heart failure aren't rhythm problems you can see on a wrist trace.
Briefer episodes. A short AFib run that ends before a recording starts or between PPG samples can slip through entirely.

The Real-World Evidence

The literature has matured since 2019. The Apple Heart Study and the Fitbit Heart Study (2022, 455,000 participants) both demonstrated that PPG-based screening can identify previously undiagnosed AFib at scale — but both also showed that the majority of alerts are false positives: only a fraction of those notified had confirmed AFib on gold-standard monitors. More recently, randomized screening trials (e.g., EQUAL) found that smartwatch-based screening increased AFib detection compared with usual care — real benefits — while raising open questions about how many detected cases actually change outcomes like stroke. The bottom line from cardiologists is converging: great for finding AFib you'd otherwise miss; not a substitute for a doctor when symptoms demand one.

How to Use It Without Driving Yourself Crazy

Record when you have symptoms — palpitations, racing or irregular heartbeats, unexplained fainting. A clean 30-second trace is genuinely useful data for your doctor.
Take alerts seriously, but not as verdicts. A notification is a reason for follow-up, ideally with a standard ECG and a clinician's interpretation.
Share, don't self-diagnose. Most devices export PDFs; send them to your physician rather than parsing them with a web search.
Ignore the noise. Occasional "inconclusive" readings, motion artifact, or hair and skin contact issues are normal — repeated or symptomatic readings are not.

The Bottom Line